Greenberg Traurig Represents ONO Pharmaceutical in $2.4B Acquisition of Deciphera Pharmaceuticals
May 01, 2024
May 01, 2024
WASHINGTON, May 1 -- Greenberg Traurig, a law firm, issued the following news release:
Global law firm Greenberg Traurig, LLP represented Japan-based global specialty pharmaceutical company ONO Pharmaceutical Co. in its acquisition of Waltham, Massachusetts-based Deciphera Pharmaceuticals for $25.60 per share in cash, for a total equity value of $2.4 billion.
The deal is expected to close in the third quarter of 2024, subject to customary closing conditions and regulato . . .
Global law firm Greenberg Traurig, LLP represented Japan-based global specialty pharmaceutical company ONO Pharmaceutical Co. in its acquisition of Waltham, Massachusetts-based Deciphera Pharmaceuticals for $25.60 per share in cash, for a total equity value of $2.4 billion.
The deal is expected to close in the third quarter of 2024, subject to customary closing conditions and regulato . . .